Inhibitory effects of (-)-α-bisabolol on LPS-induced inflammatory response in RAW264.7 macrophages

Food and Chemical Toxicology

Volumn 49, Issue 10, 2011, Pages 2580-2585

  Kim, Seungbeom ^a   Jung, Eunsun ^a   Kim, Jang Hyun ^b   Park, Young Ho ^c   Lee, Jongsung ^a   Park, Deokhoon ^a  

^a Biospectrum Life Science Institute   (South Korea)

^b Dermiskin Life Science Institute   (South Korea)

^c International University of Korea   (South Korea)

Author keywords

( ) Bisabolol; AP 1; COX 2; INOS; NF B

Indexed keywords

BISABOLOL; CYCLOOXYGENASE 2; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PROSTAGLANDIN E2; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; INFLAMMATION; MACROPHAGE; NONHUMAN; PROMOTER REGION; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; CYCLOOXYGENASE 2; DINOPROSTONE; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; SESQUITERPENES; TRANSCRIPTION FACTOR AP-1;

EID: 80051878637     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.06.076     Document Type: Article

References (30)

1. Bezerra S.B., Leal L.K., Nogueira N.A., Campos A.R. Bisabolol-induced gastroprotection against acute gastric lesions: role of prostaglandins, nitric oxide, and KATP+ channels. J. Med. Food 2009, 12:1403-1406.
2. Bhatia S.P., McGinty D., Letizia C.S., Api A.M. Fragrance material review on alpha-bisabolol. Food Chem. Toxicol. 2008, 46(Suppl 11):S72-S76.
3. Cavalieri E., Mariotto S., Fabrizi C., de Prati A.C., Gottardo R., Leone S., Berra L.V., Lauro G.M., Ciampa A.R., Suzuki H. Alpha-Bisabolol, a nontoxic natural compound, strongly induces apoptosis in glioma cells. Biochem. Biophys. Res. Commun. 2004, 315:589-594.
4. Chen F., Castranova V., Shi X., Demers L.M. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin. Chem. 1999, 45:7-17.
5. Chen W., Hou J., Yin Y., Jang J., Zheng Z., Fan H., Zou G. Alpha-Bisabolol induces dose- and time-dependent apoptosis in HepG2 cells via a Fas- and mitochondrial-related pathway, involves p53 and NFkappaB. Biochem. Pharmacol. 2010, 80:247-254.
6. da Silva A.P., Martini M.V., de Oliveira C.M., Cunha S., de Carvalho J.E., Ruiz A.L., da Silva C.C. Antitumor activity of (-)-alpha-bisabolol-based thiosemicarbazones against human tumor cell lines. Eur. J. Med. Chem. 2010, 45:2987-2993.
7. Dinarello C.A., Gatti S., Bartfai T. Fever: links with an ancient receptor. Curr. Biol. 1999, 9:R147-R150.
8. Epe B., Ballmaier D., Roussyn I., Briviba K., Sies H. DNA damage by peroxynitrite characterized with DNA repair enzymes. Nucleic Acids Res. 1996, 24:4105-4110.
9. Goldring M.B., Berenbaum F. The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin. Orthop. Relat. Res. 2004, S37-S46.
10. Hambleton J., Weinstein S.L., Lem L., DeFranco A.L. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc. Natl Acad. Sci. USA 1996, 93:2774-2778.
11. Hobbs A.J., Higgs A., Moncada S. Inhibition of nitric oxide synthase as a potential therapeutic target. Annu. Rev. Pharmacol. Toxicol. 1999, 39:191-220.
12. Jang S.H., Lim J.W., Kim H. Beta-carotene inhibits Helicobacter pylori-induced expression of inducible nitric oxide synthase and cyclooxygenase-2 in human gastric epithelial AGS cells. J. Physiol. Pharmacol. 2009, 60(Suppl 7):131-137.
13. Jiang Q., Akashi S., Miyake K., Petty H.R. Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B. J. Immunol. 2000, 165:3541-3544.
14. Kharitonov S.A., Yates D., Robbins R.A., Logan-Sinclair R., Shinebourne E.A., Barnes P.J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994, 343:133-135.
15. Kim S., Lee J., Jung E., Huh S., Park J.O., Lee J.W., Byun S.Y., Park D. Mechanisms of depigmentation by alpha-bisabolol. J. Dermatol. Sci. 2008, 52:219-222.
16. Kobayashi T., Narumiya S. Function of prostanoid receptors: studies on knockout mice. Prostaglandins Other Lipid Mediat. 2002, 68(69):557-573.
17. Korhonen R., Lahti A., Kankaanranta H., Moilanen E. Nitric oxide production and signaling in inflammation. Curr. Drug Targets Inflamm. Allergy 2005, 4:471-479.
18. Leite Gde O., Leite L.H., Sampaio Rde S., Araruna M.K., de Menezes I.R., da Costa J.G., Campos A.R. (-)-Alpha-Bisabolol attenuates visceral nociception and inflammation in mice. Fitoterapia 2011, 82:208-211.
19. Mitchell J.A., Larkin S., Williams T.J. Cyclooxygenase-2: regulation and relevance in inflammation. Biochem. Pharmacol. 1995, 50:1535-1542.
20. Muller J.M., Ziegler-Heitbrock H.W., Baeuerle P.A. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 1993, 187:233-256.
21. Piochon M., Legault J., Gauthier C., Pichette A. Synthesis and cytotoxicity evaluation of natural alpha-bisabolol beta-D-fucopyranoside and analogues. Phytochemistry 2009, 70:228-236.
22. Ramsay R.G., Ciznadija D., Vanevski M., Mantamadiotis T. Transcriptional regulation of cyclo-oxygenase expression: three pillars of control. Int. J. Immunopathol. Pharmacol. 2003, 16:59-67.
23. Sahnoun Z., Jamoussi K., Zeghal K.M. Free radicals and antioxidants: physiology, human pathology and therapeutic aspects (part II). Therapie 1998, 53:315-339.
24. Sautebin L. Prostaglandins and nitric oxide as molecular targets for anti-inflammatory therapy. Fitoterapia 2000, 71(Suppl 1):S48-S57.
25. Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 2002, 4:E131-E136.
26. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., Lee S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 2001, 480-481:243-268.
27. Tsatsanis C., Androulidaki A., Venihaki M., Margioris A.N. Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 2006, 38:1654-1661.
28. Vila R., Santana A.I., Perez-Roses R., Valderrama A., Castelli M.V., Mendonca S., Zacchino S., Gupta M.P., Canigueral S. Composition and biological activity of the essential oil from leaves of Plinia cerrocampanensis, a new source of alpha-bisabolol. Bioresour. Technol. 2010, 101:2510-2514.
29. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 1994, 269:4705-4708.
30. Zenz R., Eferl R., Scheinecker C., Redlich K., Smolen J., Schonthaler H.B., Kenner L., Tschachler E., Wagner E.F. Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease. Arthritis Res. Ther. 2008, 10:201.